Status | Study |
Recruiting |
Study Name: A Phase I, Three-part Study to Determine the Maximum Tolerated Dose/Recommended Dose, Compare Bioavailability in the Fed and Fasted States, and Evaluate Safety and Tolerability of ORH-2014 in Subjects With Advanced Hematological Disorders Condition: Advanced Hematological Disorders Date: 2017-01-31 Interventions: Drug: ORH-2014 ORH-2014 capsul |
Recruiting |
Study Name: Long-term QoL in Acute Promyelocytic Leukemia Treated With ATO or Standard Chemotherapy Condition: Acute Promyelocytic Leukemia Date: 2017-01-24 Interventions: Other: QoL questionnaires Quality of life questionnaires |
Recruiting |
Study Name: French Registry of First-line Treatment of Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2016-09-22 |
Recruiting |
Study Name: Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF) Condition: Acute Promyelocytic Leukemia Date: 2016-09-04 Interventions: Drug: Realgar-Indigo naturalis formula |
Recruiting |
Study Name: Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2016-03-02 |
Recruiting |
Study Name: Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia Condition: Acute Promyelocytic Leukemia Date: 2016-02-11 Interventions: Drug: Arsenic trioxide Other N |
Recruiting |
Study Name: Extramedullary Leukemia (EML) in Newly Diagnosed Acute Myeloid Leukemia (AML) is Underreported Condition: Leukemia Date: 2015-03-11 Interventions: Drug: 18F-FDG Participants rec |
Recruiting |
Study Name: Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia Condition: Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA Date: 2015-01-13 Interventions: Drug: Arsenic Trioxide Given I |
Active, not recruiting |
Study Name: Impact of a Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL) by Maintaining a Database Condition: Leukemia, Promyelocytic, Acute Date: 2014-12-03 |
Recruiting |
Study Name: National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup Condition: Newly-diagnosed APL (de Novo or Therapy-related) Relapsed APL Date: 2014-07-11 Interventions: Other: observational |